As Merck & Co. rolls out a widespread cost-cutting initiative, the pharma is dropping an autoimmune asset acquired a few years ago in a nearly $2 billion biotech takeover.

The Food and Drug Administration’s top vaccine and gene therapy official resigned on Tuesday after a public campaign against ...

The Trump administration has decided to extend the terms of the interim federal prosecutors in Southern California and Nevada ...

Buyouts at The Washington Post continue as the paper seeks to get rid of its most high-profile staffers in efforts to improve ...

TD, says it will try to block the merger between freight railroads Union Pacific and Norfolk Southern, citing UP labor ...

Attorney General Phil Weiser is wasting no time fulfilling his pledge to block President Trump's policy agenda with more than ...